Search For

Jennifer C Leeds, 32Bristol, NH

Jennifer Leeds Phones & Addresses

Bristol, NH   

Brookline, NH   

Worcester, MA   

22 W Hill Rd, Brookline, NH 03033   

Social networks

Jennifer C Leeds
Jennifer C Leeds

Linkedin

Awards

Pharmaceutical executive magazine's emerging pharma leaders 2011 - Pharmaceutical executive, inc.

Industries

Pharmaceuticals

Mentions for Jennifer C Leeds

Resumes

Resumes

Jennifer Leeds Photo 1

Jennifer Leeds

Location:
Emeryville, California
Industry:
Pharmaceuticals
Awards:
Pharmaceutical Executive magazine's Emerging Pharma Leaders 2011
Pharmaceutical Executive, Inc.
Pharm Exec's 2011 roster of Emerging Leaders—our fourth to date—is not only a way to recognize a few individuals who've made a difference in their organizations. It also serves as a barometer to track larger changes in the workplace: how work is done; who does it; where, and with what range of skills; and for what outcome or objective. In acknowledgment of our own 30th anniversary as a publication, and with the support of Pharm Exec's Editorial Advisory Board (EAB) and an aggressive Web-based recommendation process, we've selected 30 executives drawn from a range of mission-critical functions, varied geographies, and diverse gender and cultural characteristics. Such backgrounds were unimaginable in the executive ranks of the industry just a few years ago, a fact that suggests Big Pharma today is at least more reflective of the broader sociopolitical environment that has always been crucial to its success.

Publications

Us Patents

N-Formyl Hydrozyamine Compounds

US Patent:
2009006, Mar 5, 2009
Filed:
Mar 2, 2007
Appl. No.:
12/280896
Inventors:
Kwangho Lee - Lexington MA,
Jennifer A. Leeds - Arlington MA,
International Classification:
C07D 403/12
C07D 401/12
US Classification:
544238, 5462791, 544336
Abstract:
Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.